Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
Emilia Alors‐Pérez(Instituto de Salud Carlos III), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Bruno Sáinz(Instituto de Salud Carlos III), Sergio Pedraza‐Arévalo(Instituto Maimónides de Investigación Biomédica de Córdoba), Víctor García‐Vioque(Instituto Maimónides de Investigación Biomédica de Córdoba), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Inmaculada Berbel(Instituto Maimónides de Investigación Biomédica de Córdoba), Raúl M. Luque(Instituto de Salud Carlos III), Ricardo Blázquez‐Encinas(Instituto Maimónides de Investigación Biomédica de Córdoba), María Trinidad Moreno-Montilla(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cited by 12
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
|Pharmacological Reviews|2018|251
Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells
|Nature Communications|2020|153
DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster
|Cancer Research|2016|109